The global protein expression market is on the brink of a significant transformation, with an estimated growth rate of 10.9% CAGR by 2030. This market, valued at $4.7 billion in 2025, is projected to reach $7.9 billion by 2030. But here's where it gets controversial: the driving forces behind this growth are not just technological advancements, but also the increasing demand for therapeutic proteins and biologics to treat chronic diseases like cancer and diabetes.
The report, "Protein Expression: Global Markets," provides an in-depth analysis of this industry's trends, challenges, and opportunities. It covers revenue data from 2024 and forecasts for the next six years, segmented by expression system, product types, applications, end users, and regions. The study includes North America, Europe, Asia-Pacific, and the Rest of the World, offering detailed insights into key countries in each region.
One of the key factors driving this market is the growing demand for therapeutic proteins and biologics. The prevalence of chronic diseases has increased the need for targeted treatments with fewer side effects, leading to a surge in demand for efficient protein expression systems. Additionally, heavy investments in biopharmaceutical R&D by pharmaceutical companies and investors are accelerating innovation in protein expression technologies, improving production speed, scalability, and cost-effectiveness.
Technological advances in protein expression are also revolutionizing the market. New methods such as cell-free systems, advanced vectors, and automation have enabled faster and more accurate expression of complex proteins, reducing time-to-market for biologics. Furthermore, the broad applications of CRISPR technology in precise gene editing are supporting drug discovery and personalized medicine initiatives.
The demand for biopharmaceuticals in emerging countries is another significant driver. Increased healthcare spending and infrastructure development in Asia-Pacific, Latin America, and Africa are boosting global protein expression activities and market expansion.
The report also highlights the impact of AI on the protein expression market. Artificial intelligence, particularly machine learning, is enabling groundbreaking innovations, such as designing proteins with specific functions from scratch and optimizing expression conditions for maximum yield and stability. AI also facilitates high-throughput screening of protein variants and cell-free expression systems, accelerating development timelines.
In terms of market segments, the report covers expression systems, product types, applications, end users, and regions. The protein expression market is currently dominated by mammalian cell expression systems, particularly CHO cells, which are favored for manufacturing complex therapeutic proteins. North America is the leading region in terms of revenue contribution, driven by the growing demand for therapeutic proteins and the expanding use of biologics, including monoclonal antibodies and cell and gene therapies.
The report addresses key questions, including the projected market size and growth rate, the factors driving the market's growth, and the challenges and opportunities it presents. It also provides an analysis of the dominant product segment through 2030 and the region with the largest market share. Leading companies in this market include AGILENT TECHNOLOGIES INC., BIO-RAD LABORATORIES INC., and CORNING INC., among others.
For those interested in further analysis, the complete AI Impact on the Protein Expression Market - BCC Pulse Report is available. Additionally, related reports on proteomics technologies and biologic therapeutic drugs provide in-depth insights into these markets.
To purchase a copy of the report or for further information, contact info@bccresearch.com. BCC Research's market research reports offer unbiased measurement and assessment of market opportunities, helping businesses make informed decisions.
